| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | SVP, Chief Business Officer
2 companies
Gros David-Alexandre C is a Chief Executive Officer at Eledon Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $67K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,000 | $4.48 | $8,960.00 | +28.6% | -22.9% | -46.5% | |
| Aug 17, 2021 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 4,000 | $6.21 | $24,840.00 | +133.3% | -13.1% | -47.7% | |
| Jun 9, 2021 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 3,000 | $8.01 | $24,030.00 | New | -0.7% | -58.1% | |
| Feb 22, 2016 | ALNY Alnylam Pharmaceuticals, Inc. | SVP, Chief Business Officer | Buy | 1,000 | $62.75 | $62,749.00 | +1,000% | - | - |